This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2o1y
From Proteopedia
(Difference between revisions)
| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| + | |||
==Solution structure of the anti-apoptotic protein Bcl-xL in complex with an acyl-sulfonamide-based ligand== | ==Solution structure of the anti-apoptotic protein Bcl-xL in complex with an acyl-sulfonamide-based ligand== | ||
| - | <StructureSection load='2o1y' size='340' side='right' caption='[[2o1y | + | <StructureSection load='2o1y' size='340' side='right'caption='[[2o1y]]' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[2o1y]] is a 1 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[2o1y]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2O1Y OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2O1Y FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=43B:3-NITRO-N-{4-[2-(2-PHENYLETHYL)-1,3-BENZOTHIAZOL-5-YL]BENZOYL}-4-{[2-(PHENYLSULFANYL)ETHYL]AMINO}BENZENESULFONAMIDE'>43B</scene> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> |
| - | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=43B:3-NITRO-N-{4-[2-(2-PHENYLETHYL)-1,3-BENZOTHIAZOL-5-YL]BENZOYL}-4-{[2-(PHENYLSULFANYL)ETHYL]AMINO}BENZENESULFONAMIDE'>43B</scene></td></tr> | |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2o1y FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2o1y OCA], [https://pdbe.org/2o1y PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2o1y RCSB], [https://www.ebi.ac.uk/pdbsum/2o1y PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2o1y ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
| - | [ | + | [https://www.uniprot.org/uniprot/B2CL1_HUMAN B2CL1_HUMAN] Potent inhibitor of cell death. Inhibits activation of caspases (By similarity). Appears to regulate cell death by blocking the voltage-dependent anion channel (VDAC) by binding to it and preventing the release of the caspase activator, CYC1, from the mitochondrial membrane. Also acts as a regulator of G2 checkpoint and progression to cytokinesis during mitosis.<ref>PMID:19917720</ref> <ref>PMID:21840391</ref> Isoform Bcl-X(S) promotes apoptosis.<ref>PMID:19917720</ref> <ref>PMID:21840391</ref> |
== Evolutionary Conservation == | == Evolutionary Conservation == | ||
[[Image:Consurf_key_small.gif|200px|right]] | [[Image:Consurf_key_small.gif|200px|right]] | ||
Check<jmol> | Check<jmol> | ||
<jmolCheckbox> | <jmolCheckbox> | ||
| - | <scriptWhenChecked>select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/o1/2o1y_consurf.spt"</scriptWhenChecked> | + | <scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/o1/2o1y_consurf.spt"</scriptWhenChecked> |
<scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked> | <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked> | ||
<text>to colour the structure by Evolutionary Conservation</text> | <text>to colour the structure by Evolutionary Conservation</text> | ||
| Line 30: | Line 31: | ||
==See Also== | ==See Also== | ||
| - | *[[ | + | *[[B-cell lymphoma proteins 3D structures|B-cell lymphoma proteins 3D structures]] |
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Homo sapiens]] |
| - | [[Category: Belli | + | [[Category: Large Structures]] |
| - | [[Category: Bruncko | + | [[Category: Belli BA]] |
| - | [[Category: Ding | + | [[Category: Bruncko M]] |
| - | [[Category: Elmore | + | [[Category: Ding H]] |
| - | [[Category: Fesik | + | [[Category: Elmore SW]] |
| - | [[Category: Joseph | + | [[Category: Fesik SW]] |
| - | [[Category: Kunzer | + | [[Category: Joseph MK]] |
| - | [[Category: Martineau | + | [[Category: Kunzer A]] |
| - | [[Category: McClellan | + | [[Category: Martineau D]] |
| - | [[Category: Mitten | + | [[Category: McClellan WJ]] |
| - | [[Category: Ng | + | [[Category: Mitten M]] |
| - | [[Category: Nimmer | + | [[Category: Ng SC]] |
| - | [[Category: Oltersdorf | + | [[Category: Nimmer PM]] |
| - | [[Category: Oost | + | [[Category: Oltersdorf T]] |
| - | [[Category: Park | + | [[Category: Oost TK]] |
| - | [[Category: Petros | + | [[Category: Park CM]] |
| - | [[Category: Rosenberg | + | [[Category: Petros AM]] |
| - | [[Category: Shoemaker | + | [[Category: Rosenberg SH]] |
| - | [[Category: Song | + | [[Category: Shoemaker AR]] |
| - | [[Category: Wang | + | [[Category: Song X]] |
| - | [[Category: Wendt | + | [[Category: Wang X]] |
| - | [[Category: Zhang | + | [[Category: Wendt MD]] |
| - | + | [[Category: Zhang H]] | |
| - | + | ||
| - | + | ||
Current revision
Solution structure of the anti-apoptotic protein Bcl-xL in complex with an acyl-sulfonamide-based ligand
| |||||||||||
Categories: Homo sapiens | Large Structures | Belli BA | Bruncko M | Ding H | Elmore SW | Fesik SW | Joseph MK | Kunzer A | Martineau D | McClellan WJ | Mitten M | Ng SC | Nimmer PM | Oltersdorf T | Oost TK | Park CM | Petros AM | Rosenberg SH | Shoemaker AR | Song X | Wang X | Wendt MD | Zhang H

